Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.
ENYO-Pharma, Lyon, France.
EMBO Rep. 2020 Dec 3;21(12):e49019. doi: 10.15252/embr.201949019. Epub 2020 Nov 12.
Several human pathologies including neurological, cardiac, infectious, cancerous, and metabolic diseases have been associated with altered mitochondria morphodynamics. Here, we identify a small organic molecule, which we named Mito-C. Mito-C is targeted to mitochondria and rapidly provokes mitochondrial network fragmentation. Biochemical analyses reveal that Mito-C is a member of a new class of heterocyclic compounds that target the NEET protein family, previously reported to regulate mitochondrial iron and ROS homeostasis. One of the NEET proteins, NAF-1, is identified as an important regulator of mitochondria morphodynamics that facilitates recruitment of DRP1 to the ER-mitochondria interface. Consistent with the observation that certain viruses modulate mitochondrial morphogenesis as a necessary part of their replication cycle, Mito-C counteracts dengue virus-induced mitochondrial network hyperfusion and represses viral replication. The newly identified chemical class including Mito-C is of therapeutic relevance for pathologies where altered mitochondria dynamics is part of disease etiology and NEET proteins are highlighted as important therapeutic targets in anti-viral research.
几种人类疾病,包括神经、心脏、感染、癌症和代谢疾病,都与线粒体形态动力学的改变有关。在这里,我们鉴定出一种小分子,我们将其命名为 Mito-C。Mito-C 靶向线粒体,并迅速引发线粒体网络碎片化。生化分析表明,Mito-C 是一类新的杂环化合物,靶向先前报道的调节线粒体铁和 ROS 稳态的 NEET 蛋白家族。NEET 蛋白之一,NAF-1,被确定为调节线粒体形态动力学的重要调节剂,促进 DRP1 招募到 ER-线粒体界面。与某些病毒将线粒体形态发生作为其复制周期的必要部分进行调节的观察结果一致,Mito-C 可拮抗登革热病毒诱导的线粒体网络过度融合并抑制病毒复制。包括 Mito-C 在内的新鉴定的化学类药物对于那些线粒体动力学改变是疾病病因一部分的病理具有治疗相关性,并且 NEET 蛋白被强调为抗病毒研究中的重要治疗靶点。